Cancro, diabetes, alergias e problemas cardiovasculares foram as doenças mais afetadas pela falha de medicamentos em 2024, 14 ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback